| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | fourth ventricle development | 4.44e-05 | 2 | 138 | 2 | GO:0021592 | |
| GeneOntologyBiologicalProcess | fibroblast growth factor receptor signaling pathway | 5.11e-05 | 98 | 138 | 6 | GO:0008543 | |
| GeneOntologyBiologicalProcess | brain development | MYH10 IFT172 BBS4 DUOX2 PBX4 EXT1 NRP1 FANCD2 DOCK7 KDM2B FGF2 FGFR1 HERC1 DNAH5 AIM2 ATP2B2 AGTPBP1 | 6.20e-05 | 859 | 138 | 17 | GO:0007420 |
| GeneOntologyBiologicalProcess | coronary vasculature morphogenesis | 7.61e-05 | 34 | 138 | 4 | GO:0060977 | |
| GeneOntologyBiologicalProcess | endothelial cell chemotaxis | 8.55e-05 | 35 | 138 | 4 | GO:0035767 | |
| GeneOntologyBiologicalProcess | lateral ventricle development | 1.01e-04 | 14 | 138 | 3 | GO:0021670 | |
| GeneOntologyBiologicalProcess | forebrain development | MYH10 BBS4 DUOX2 EXT1 NRP1 DOCK7 KDM2B FGF2 FGFR1 HERC1 DNAH5 AGTPBP1 | 1.13e-04 | 489 | 138 | 12 | GO:0030900 |
| GeneOntologyBiologicalProcess | ventricular system development | 1.19e-04 | 38 | 138 | 4 | GO:0021591 | |
| GeneOntologyBiologicalProcess | cerebellar Purkinje cell layer development | 1.32e-04 | 39 | 138 | 4 | GO:0021680 | |
| GeneOntologyBiologicalProcess | positive regulation of cell chemotaxis to fibroblast growth factor | 1.33e-04 | 3 | 138 | 2 | GO:1904849 | |
| GeneOntologyBiologicalProcess | positive regulation of endothelial cell chemotaxis to fibroblast growth factor | 1.33e-04 | 3 | 138 | 2 | GO:2000546 | |
| GeneOntologyBiologicalProcess | central nervous system development | RAB23 MYH10 IFT172 BBS4 DUOX2 PBX4 EXT1 NRP1 FANCD2 EIF2B1 DOCK7 KDM2B FGF2 FGFR1 HERC1 DNAH5 AIM2 ATP2B2 IL33 AGTPBP1 | 1.40e-04 | 1197 | 138 | 20 | GO:0007417 |
| GeneOntologyBiologicalProcess | head development | MYH10 IFT172 BBS4 DUOX2 PBX4 EXT1 NRP1 FANCD2 DOCK7 KDM2B FGF2 FGFR1 HERC1 DNAH5 AIM2 ATP2B2 AGTPBP1 | 1.40e-04 | 919 | 138 | 17 | GO:0060322 |
| GeneOntologyBiologicalProcess | positive regulation of endothelial cell chemotaxis | 1.86e-04 | 17 | 138 | 3 | GO:2001028 | |
| GeneOntologyBiologicalProcess | cellular response to fibroblast growth factor stimulus | 1.88e-04 | 124 | 138 | 6 | GO:0044344 | |
| GeneOntologyBiologicalProcess | positive regulation of developmental growth | 2.05e-04 | 238 | 138 | 8 | GO:0048639 | |
| GeneOntologyBiologicalProcess | postsynaptic specialization assembly | 2.12e-04 | 44 | 138 | 4 | GO:0098698 | |
| GeneOntologyBiologicalProcess | tumor necrosis factor-mediated signaling pathway | 2.14e-04 | 127 | 138 | 6 | GO:0033209 | |
| GeneOntologyBiologicalProcess | vasculogenesis involved in coronary vascular morphogenesis | 2.22e-04 | 18 | 138 | 3 | GO:0060979 | |
| GeneOntologyBiologicalProcess | cerebellar Purkinje cell differentiation | 2.22e-04 | 18 | 138 | 3 | GO:0021702 | |
| GeneOntologyBiologicalProcess | coronary vasculature development | 2.38e-04 | 83 | 138 | 5 | GO:0060976 | |
| GeneOntologyBiologicalProcess | response to fibroblast growth factor | 2.64e-04 | 132 | 138 | 6 | GO:0071774 | |
| GeneOntologyBiologicalProcess | cerebellar Purkinje cell layer formation | 3.07e-04 | 20 | 138 | 3 | GO:0021694 | |
| Domain | LYZL1/LYZL2 | 5.42e-05 | 2 | 138 | 2 | IPR030057 | |
| Domain | Dynein_heavy_chain_D4_dom | 1.35e-04 | 14 | 138 | 3 | IPR024317 | |
| Domain | Dynein_HC_stalk | 1.35e-04 | 14 | 138 | 3 | IPR024743 | |
| Domain | MT | 1.35e-04 | 14 | 138 | 3 | PF12777 | |
| Domain | AAA_8 | 1.35e-04 | 14 | 138 | 3 | PF12780 | |
| Domain | Cytokine_IL1-like | 1.40e-04 | 36 | 138 | 4 | IPR008996 | |
| Domain | DHC_fam | 1.68e-04 | 15 | 138 | 3 | IPR026983 | |
| Domain | Dynein_heavy | 1.68e-04 | 15 | 138 | 3 | PF03028 | |
| Domain | Dynein_heavy_dom | 1.68e-04 | 15 | 138 | 3 | IPR004273 | |
| Domain | - | 5.34e-04 | 5 | 138 | 2 | 2.40.290.10 | |
| Domain | Sortilin_C | 5.34e-04 | 5 | 138 | 2 | PF15901 | |
| Domain | Sortilin-Vps10 | 5.34e-04 | 5 | 138 | 2 | PF15902 | |
| Domain | VPS10 | 5.34e-04 | 5 | 138 | 2 | IPR006581 | |
| Domain | Sortilin_N | 5.34e-04 | 5 | 138 | 2 | IPR031778 | |
| Domain | Sortilin_C | 5.34e-04 | 5 | 138 | 2 | IPR031777 | |
| Domain | HnRNP_R/Q_splicing_fac | 5.34e-04 | 5 | 138 | 2 | IPR006535 | |
| Domain | VPS10 | 5.34e-04 | 5 | 138 | 2 | SM00602 | |
| Domain | SPOC-like_C_dom | 5.34e-04 | 5 | 138 | 2 | IPR016194 | |
| Domain | FGF | 5.48e-04 | 22 | 138 | 3 | PF00167 | |
| Domain | HBGF_FGF | 5.48e-04 | 22 | 138 | 3 | PS00247 | |
| Domain | FGF | 5.48e-04 | 22 | 138 | 3 | SM00442 | |
| Domain | Fibroblast_GF_fam | 5.48e-04 | 22 | 138 | 3 | IPR002209 | |
| Domain | IL-1_fam/FGF_fam | 6.27e-04 | 23 | 138 | 3 | IPR028142 | |
| Domain | TRP_2 | 7.97e-04 | 6 | 138 | 2 | PF08344 | |
| Domain | TRP_dom | 7.97e-04 | 6 | 138 | 2 | IPR013555 | |
| Domain | PKD | 1.11e-03 | 7 | 138 | 2 | PF00801 | |
| Domain | Glyco_hydro_22_lys | 1.11e-03 | 7 | 138 | 2 | IPR000974 | |
| Domain | Glyco_hydro_22_CS | 1.11e-03 | 7 | 138 | 2 | IPR019799 | |
| Domain | TRPC_channel | 1.11e-03 | 7 | 138 | 2 | IPR002153 | |
| Domain | Glyco_hydro_22 | 1.47e-03 | 8 | 138 | 2 | IPR001916 | |
| Domain | LACTALBUMIN_LYSOZYME_2 | 1.47e-03 | 8 | 138 | 2 | PS51348 | |
| Domain | Lys | 1.47e-03 | 8 | 138 | 2 | PF00062 | |
| Domain | LACTALBUMIN_LYSOZYME_1 | 1.47e-03 | 8 | 138 | 2 | PS00128 | |
| Domain | LYZ1 | 1.47e-03 | 8 | 138 | 2 | SM00263 | |
| Domain | Sialidases | 1.89e-03 | 9 | 138 | 2 | IPR011040 | |
| Pathway | REACTOME_SIGNALING_BY_ACTIVATED_POINT_MUTANTS_OF_FGFR1 | 6.34e-05 | 11 | 105 | 3 | M675 | |
| Pathway | KEGG_MEDICUS_REFERENCE_FGF_FGFR_PI3K_SIGNALING_PATHWAY | 7.83e-05 | 31 | 105 | 4 | M47396 | |
| Pathway | REACTOME_FGFR2C_LIGAND_BINDING_AND_ACTIVATION | 8.41e-05 | 12 | 105 | 3 | MM14728 | |
| Pathway | REACTOME_FGFRL1_MODULATION_OF_FGFR1_SIGNALING | 1.09e-04 | 13 | 105 | 3 | M27540 | |
| Pathway | REACTOME_FGFRL1_MODULATION_OF_FGFR1_SIGNALING | 1.09e-04 | 13 | 105 | 3 | MM15262 | |
| Pathway | REACTOME_FGFR2C_LIGAND_BINDING_AND_ACTIVATION | 1.09e-04 | 13 | 105 | 3 | M1087 | |
| Pathway | REACTOME_FGFR3_LIGAND_BINDING_AND_ACTIVATION | 1.09e-04 | 13 | 105 | 3 | M27061 | |
| Pathway | REACTOME_FGFR3_LIGAND_BINDING_AND_ACTIVATION | 1.09e-04 | 13 | 105 | 3 | MM14723 | |
| Pathway | REACTOME_FGFR1C_LIGAND_BINDING_AND_ACTIVATION | 1.09e-04 | 13 | 105 | 3 | MM14727 | |
| Pathway | KEGG_MEDICUS_REFERENCE_FGF_FGFR_RAS_ERK_SIGNALING_PATHWAY | 1.27e-04 | 35 | 105 | 4 | M47379 | |
| Pathway | REACTOME_FGFR1C_LIGAND_BINDING_AND_ACTIVATION | 1.38e-04 | 14 | 105 | 3 | M27065 | |
| Pathway | REACTOME_PHOSPHOLIPASE_C_MEDIATED_CASCADE_FGFR4 | 1.71e-04 | 15 | 105 | 3 | M27509 | |
| Pathway | REACTOME_PHOSPHOLIPASE_C_MEDIATED_CASCADE_FGFR4 | 1.71e-04 | 15 | 105 | 3 | MM15235 | |
| Pathway | REACTOME_PHOSPHOLIPASE_C_MEDIATED_CASCADE_FGFR1 | 2.10e-04 | 16 | 105 | 3 | M48007 | |
| Pathway | REACTOME_PHOSPHOLIPASE_C_MEDIATED_CASCADE_FGFR1 | 2.10e-04 | 16 | 105 | 3 | MM15233 | |
| Pathway | REACTOME_IRS_MEDIATED_SIGNALLING | 2.38e-04 | 41 | 105 | 4 | MM14505 | |
| Pathway | REACTOME_FGFR1_LIGAND_BINDING_AND_ACTIVATION | 2.53e-04 | 17 | 105 | 3 | MM17066 | |
| Pathway | REACTOME_PHOSPHOLIPASE_C_MEDIATED_CASCADE_FGFR2 | 2.53e-04 | 17 | 105 | 3 | MM15234 | |
| Pathway | REACTOME_SHC_MEDIATED_CASCADE_FGFR3 | 2.53e-04 | 17 | 105 | 3 | MM15244 | |
| Pathway | REACTOME_PHOSPHOLIPASE_C_MEDIATED_CASCADE_FGFR2 | 3.02e-04 | 18 | 105 | 3 | M27508 | |
| Pathway | REACTOME_SHC_MEDIATED_CASCADE_FGFR3 | 3.02e-04 | 18 | 105 | 3 | M27518 | |
| Pathway | REACTOME_PI_3K_CASCADE_FGFR3 | 3.02e-04 | 18 | 105 | 3 | M27521 | |
| Pathway | REACTOME_FGFR1_LIGAND_BINDING_AND_ACTIVATION | 3.02e-04 | 18 | 105 | 3 | M1092 | |
| Pathway | REACTOME_PI_3K_CASCADE_FGFR3 | 3.02e-04 | 18 | 105 | 3 | MM15247 | |
| Pathway | REACTOME_FGFR2_LIGAND_BINDING_AND_ACTIVATION | 3.02e-04 | 18 | 105 | 3 | MM14724 | |
| Pathway | REACTOME_SHC_MEDIATED_CASCADE_FGFR4 | 3.57e-04 | 19 | 105 | 3 | MM15250 | |
| Pathway | REACTOME_FRS_MEDIATED_FGFR3_SIGNALING | 3.57e-04 | 19 | 105 | 3 | MM15245 | |
| Pathway | REACTOME_SIGNALING_BY_TYPE_1_INSULIN_LIKE_GROWTH_FACTOR_1_RECEPTOR_IGF1R | 4.05e-04 | 47 | 105 | 4 | MM14885 | |
| Pathway | REACTOME_FRS_MEDIATED_FGFR3_SIGNALING | 4.17e-04 | 20 | 105 | 3 | M27519 | |
| Pathway | REACTOME_PI_3K_CASCADE_FGFR4 | 4.17e-04 | 20 | 105 | 3 | M27525 | |
| Pathway | REACTOME_SHC_MEDIATED_CASCADE_FGFR4 | 4.17e-04 | 20 | 105 | 3 | M27524 | |
| Pathway | REACTOME_PI_3K_CASCADE_FGFR4 | 4.17e-04 | 20 | 105 | 3 | MM15251 | |
| Pathway | REACTOME_FGFR2_LIGAND_BINDING_AND_ACTIVATION | 4.17e-04 | 20 | 105 | 3 | M27062 | |
| Pathway | REACTOME_SHC_MEDIATED_CASCADE_FGFR1 | 4.17e-04 | 20 | 105 | 3 | MM15237 | |
| Pathway | REACTOME_IRS_MEDIATED_SIGNALLING | 4.40e-04 | 48 | 105 | 4 | M26916 | |
| Pathway | REACTOME_INSULIN_RECEPTOR_SIGNALLING_CASCADE | 4.40e-04 | 48 | 105 | 4 | MM15441 | |
| Pathway | REACTOME_PI_3K_CASCADE_FGFR1 | 4.84e-04 | 21 | 105 | 3 | M27512 | |
| Pathway | REACTOME_SHC_MEDIATED_CASCADE_FGFR1 | 4.84e-04 | 21 | 105 | 3 | M27511 | |
| Pathway | REACTOME_PI_3K_CASCADE_FGFR1 | 4.84e-04 | 21 | 105 | 3 | MM15238 | |
| Pathway | REACTOME_FRS_MEDIATED_FGFR4_SIGNALING | 4.84e-04 | 21 | 105 | 3 | MM15248 | |
| Pathway | REACTOME_SHC_MEDIATED_CASCADE_FGFR2 | 4.84e-04 | 21 | 105 | 3 | MM15242 | |
| Pathway | REACTOME_SIGNALING_BY_FGFR1 | 5.14e-04 | 50 | 105 | 4 | MM15255 | |
| Pathway | REACTOME_FRS_MEDIATED_FGFR4_SIGNALING | 5.58e-04 | 22 | 105 | 3 | M27522 | |
| Pathway | REACTOME_FRS_MEDIATED_FGFR1_SIGNALING | 5.58e-04 | 22 | 105 | 3 | MM15239 | |
| Pathway | REACTOME_PI_3K_CASCADE_FGFR2 | 5.58e-04 | 22 | 105 | 3 | MM15240 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | DOCK3 FGF18 FGF17 NRP1 PTPN2 COL24A1 AP2M1 DOCK7 FGF2 VAV3 FGFR1 MAPK13 | 5.90e-04 | 532 | 105 | 12 | M27870 |
| Pathway | REACTOME_SIGNALING_BY_FGFR1 | 5.98e-04 | 52 | 105 | 4 | M27530 | |
| Pathway | REACTOME_PI_3K_CASCADE_FGFR2 | 6.38e-04 | 23 | 105 | 3 | M27514 | |
| Pathway | REACTOME_FRS_MEDIATED_FGFR1_SIGNALING | 6.38e-04 | 23 | 105 | 3 | M27513 | |
| Pathway | REACTOME_FRS_MEDIATED_FGFR2_SIGNALING | 6.38e-04 | 23 | 105 | 3 | MM15243 | |
| Pathway | REACTOME_SIGNALING_BY_TYPE_1_INSULIN_LIKE_GROWTH_FACTOR_1_RECEPTOR_IGF1R | 6.90e-04 | 54 | 105 | 4 | M27168 | |
| Pathway | REACTOME_INSULIN_RECEPTOR_SIGNALLING_CASCADE | 6.90e-04 | 54 | 105 | 4 | M620 | |
| Pathway | REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR3 | 7.25e-04 | 24 | 105 | 3 | MM15246 | |
| Pathway | PID_FGF_PATHWAY | 7.40e-04 | 55 | 105 | 4 | M276 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RTK_PLCG_ITPR_SIGNALING_PATHWAY | 7.40e-04 | 55 | 105 | 4 | M47952 | |
| Pathway | REACTOME_FRS_MEDIATED_FGFR2_SIGNALING | 8.20e-04 | 25 | 105 | 3 | M27517 | |
| Pathway | REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR3 | 8.20e-04 | 25 | 105 | 3 | M27520 | |
| Pathway | REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR4 | 9.22e-04 | 26 | 105 | 3 | MM15249 | |
| Pathway | REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR4 | 1.03e-03 | 27 | 105 | 3 | M27523 | |
| Pathway | PID_AR_PATHWAY | 1.09e-03 | 61 | 105 | 4 | M58 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | 1.11e-03 | 418 | 105 | 10 | MM15587 | |
| Pathway | REACTOME_FGFR3B_LIGAND_BINDING_AND_ACTIVATION | 1.13e-03 | 7 | 105 | 2 | M27064 | |
| Pathway | REACTOME_FGFR3B_LIGAND_BINDING_AND_ACTIVATION | 1.13e-03 | 7 | 105 | 2 | MM14726 | |
| Pathway | REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR2 | 1.15e-03 | 28 | 105 | 3 | MM15241 | |
| Pathway | REACTOME_SIGNALING_BY_FGFR_IN_DISEASE | 1.24e-03 | 63 | 105 | 4 | M635 | |
| Pathway | WP_ENDOCHONDRAL_OSSIFICATION_WITH_SKELETAL_DYSPLASIAS | 1.24e-03 | 63 | 105 | 4 | M39884 | |
| Pathway | WP_ENDOCHONDRAL_OSSIFICATION | 1.24e-03 | 63 | 105 | 4 | M39646 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_FGFR3_SIGNALING | 1.27e-03 | 29 | 105 | 3 | M27528 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_FGFR3_SIGNALING | 1.27e-03 | 29 | 105 | 3 | MM15253 | |
| Pathway | REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR2 | 1.41e-03 | 30 | 105 | 3 | M27515 | |
| Pathway | REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR1 | 1.41e-03 | 30 | 105 | 3 | MM15236 | |
| Pathway | WP_ENDOCHONDRAL_OSSIFICATION | 1.47e-03 | 66 | 105 | 4 | MM15875 | |
| Pathway | REACTOME_FGFR1B_LIGAND_BINDING_AND_ACTIVATION | 1.49e-03 | 8 | 105 | 2 | M27063 | |
| Pathway | REACTOME_FGFR1B_LIGAND_BINDING_AND_ACTIVATION | 1.49e-03 | 8 | 105 | 2 | MM14725 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK | 1.55e-03 | 113 | 105 | 5 | MM14783 | |
| Pathway | REACTOME_FGFR1_MUTANT_RECEPTOR_ACTIVATION | 1.55e-03 | 31 | 105 | 3 | M661 | |
| Pathway | REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR1 | 1.55e-03 | 31 | 105 | 3 | M27510 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_FGFR4_SIGNALING | 1.55e-03 | 31 | 105 | 3 | M27529 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_FGFR4_SIGNALING | 1.55e-03 | 31 | 105 | 3 | MM15254 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_FGFR1_SIGNALING | 1.86e-03 | 33 | 105 | 3 | M27526 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_FGFR2_SIGNALING | 1.86e-03 | 33 | 105 | 3 | MM15252 | |
| Pathway | REACTOME_FGFR2_MUTANT_RECEPTOR_ACTIVATION | 1.86e-03 | 33 | 105 | 3 | M27049 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK | 1.87e-03 | 118 | 105 | 5 | M713 | |
| Pathway | KEGG_MELANOMA | 1.93e-03 | 71 | 105 | 4 | M15798 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_FGFR2_SIGNALING | 2.03e-03 | 34 | 105 | 3 | M27527 | |
| Pathway | REACTOME_ROLE_OF_SECOND_MESSENGERS_IN_NETRIN_1_SIGNALING | 2.38e-03 | 10 | 105 | 2 | M27330 | |
| Pathway | WP_NONHOMOLOGOUS_END_JOINING | 2.38e-03 | 10 | 105 | 2 | M39469 | |
| Pathway | REACTOME_SIGNALING_BY_INSULIN_RECEPTOR | 2.47e-03 | 76 | 105 | 4 | MM15442 | |
| Pathway | REACTOME_SIGNALING_BY_FGFR | 2.59e-03 | 77 | 105 | 4 | MM14722 | |
| Pathway | REACTOME_SIGNALING_BY_FGFR1_IN_DISEASE | 2.80e-03 | 38 | 105 | 3 | M27536 | |
| Pathway | REACTOME_ASPARTATE_AND_ASPARAGINE_METABOLISM | 2.89e-03 | 11 | 105 | 2 | M27836 | |
| Pathway | REACTOME_SIGNALING_BY_FGFR3 | 3.02e-03 | 39 | 105 | 3 | MM15257 | |
| Pathway | WP_DNA_IRDAMAGE_AND_CELLULAR_RESPONSE_VIA_ATR | 3.12e-03 | 81 | 105 | 4 | M39490 | |
| Pathway | REACTOME_SIGNALING_BY_FGFR3 | 3.25e-03 | 40 | 105 | 3 | M27532 | |
| Pathway | REACTOME_SIGNALING_BY_FGFR4 | 3.25e-03 | 40 | 105 | 3 | MM15258 | |
| Pathway | REACTOME_SIGNALING_BY_INSULIN_RECEPTOR | 3.26e-03 | 82 | 105 | 4 | M1021 | |
| Pathway | REACTOME_CONSTITUTIVE_SIGNALING_BY_ABERRANT_PI3K_IN_CANCER | 3.40e-03 | 83 | 105 | 4 | M27163 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GF_RTK_PI3K_SIGNALING_PATHWAY | 3.40e-03 | 83 | 105 | 4 | M47961 | |
| Pathway | REACTOME_ASPARTATE_AND_ASPARAGINE_METABOLISM | 3.45e-03 | 12 | 105 | 2 | MM15556 | |
| Pathway | REACTOME_SIGNALING_BY_FGFR4 | 3.49e-03 | 41 | 105 | 3 | M27533 | |
| Pubmed | 5.49e-08 | 10 | 142 | 4 | 1697263 | ||
| Pubmed | 6.66e-08 | 3 | 142 | 3 | 35562616 | ||
| Pubmed | Receptor specificity of the fibroblast growth factor family. The complete mammalian FGF family. | 9.84e-07 | 19 | 142 | 4 | 16597617 | |
| Pubmed | 1.32e-06 | 6 | 142 | 3 | 9010207 | ||
| Pubmed | 1.32e-06 | 6 | 142 | 3 | 29563520 | ||
| Pubmed | 1.51e-06 | 21 | 142 | 4 | 10579907 | ||
| Pubmed | MYH10 ELOA2 PRELID1 MYH13 DBNL DUOX2 XRCC5 DDX11 CREBRF AP2M1 NRXN3 ZBED4 SLC25A13 FGFR1 SPEN RPL3 ATP2B2 GABPA SYNCRIP HNRNPR | 1.79e-06 | 1442 | 142 | 20 | 35575683 | |
| Pubmed | Expression of members of the Fgf family and their receptors during midfacial development. | 1.84e-06 | 22 | 142 | 4 | 11165488 | |
| Pubmed | 2.30e-06 | 7 | 142 | 3 | 10704889 | ||
| Pubmed | 2.30e-06 | 7 | 142 | 3 | 15695515 | ||
| Pubmed | 3.68e-06 | 8 | 142 | 3 | 14602678 | ||
| Pubmed | 3.68e-06 | 8 | 142 | 3 | 19218784 | ||
| Pubmed | Expression of Fgf signalling pathway related genes during palatal rugae development in the mouse. | 3.71e-06 | 26 | 142 | 4 | 20348033 | |
| Pubmed | 3.84e-06 | 101 | 142 | 6 | 18519826 | ||
| Pubmed | 4.35e-06 | 27 | 142 | 4 | 19544582 | ||
| Pubmed | 5.50e-06 | 9 | 142 | 3 | 9139660 | ||
| Pubmed | 5.84e-06 | 29 | 142 | 4 | 21876757 | ||
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | MYH10 NSF DBNL DUOX2 XRCC5 TSFM FANCD2 AP2M1 PBRM1 EIF2B1 SLC25A13 DOCK7 SPEN DNAH5 RPL3 HNRNPLL SYNCRIP HNRNPR HDGF | 5.85e-06 | 1425 | 142 | 19 | 30948266 |
| Pubmed | 7.69e-06 | 31 | 142 | 4 | 16123981 | ||
| Pubmed | 7.83e-06 | 10 | 142 | 3 | 15470137 | ||
| Pubmed | 1.07e-05 | 11 | 142 | 3 | 18199118 | ||
| Pubmed | 1.43e-05 | 12 | 142 | 3 | 10751172 | ||
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 16829530 | ||
| Pubmed | FGF-2 and FGFR-1 might be independent prognostic factors in oral tongue squamous cell carcinoma. | 1.66e-05 | 2 | 142 | 2 | 30129658 | |
| Pubmed | SORCS1 and SORCS3 control energy balance and orexigenic peptide production. | 1.66e-05 | 2 | 142 | 2 | 29440124 | |
| Pubmed | FGF signaling facilitates postinjury recovery of mouse hematopoietic system. | 1.66e-05 | 2 | 142 | 2 | 22802336 | |
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 33983622 | ||
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 3678603 | ||
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 30720426 | ||
| Pubmed | Structural basis for activation of fibroblast growth factor signaling by sucrose octasulfate. | 1.66e-05 | 2 | 142 | 2 | 12242295 | |
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 16949906 | ||
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 9256280 | ||
| Pubmed | Prostaglandin E2 regulates angiogenesis via activation of fibroblast growth factor receptor-1. | 1.66e-05 | 2 | 142 | 2 | 18042549 | |
| Pubmed | Anti-apoptotic Bcl-2 enhancing requires FGF-2/FGF receptor 1 binding in mouse osteoblasts. | 1.66e-05 | 2 | 142 | 2 | 17559077 | |
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 30080932 | ||
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 9174056 | ||
| Pubmed | FGFR1 mediates recombinant thrombomodulin domain-induced angiogenesis. | 1.66e-05 | 2 | 142 | 2 | 25388665 | |
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 24375670 | ||
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 15297314 | ||
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 33800200 | ||
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 33285208 | ||
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 26617686 | ||
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 24503018 | ||
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 11786412 | ||
| Pubmed | Leucine-rich repeat, immunoglobulin-like and transmembrane domain 3 (LRIT3) is a modulator of FGFR1. | 1.66e-05 | 2 | 142 | 2 | 22673519 | |
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 21942441 | ||
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 32531052 | ||
| Pubmed | FGF2 and FGFR1 signaling regulate functional recovery following cuprizone demyelination. | 1.66e-05 | 2 | 142 | 2 | 23684572 | |
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 7520751 | ||
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 21124973 | ||
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 15680705 | ||
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 31916307 | ||
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 19096867 | ||
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 8868466 | ||
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 32557854 | ||
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 25924845 | ||
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 18180189 | ||
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 12080186 | ||
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 23536707 | ||
| Pubmed | Identification and characterization of SorCS, a third member of a novel receptor family. | 1.66e-05 | 2 | 142 | 2 | 10600506 | |
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 19713533 | ||
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 14505356 | ||
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 38272512 | ||
| Pubmed | Structural basis for FGF receptor dimerization and activation. | 1.66e-05 | 2 | 142 | 2 | 10490103 | |
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 32324534 | ||
| Pubmed | Role and regulation of the fibroblast growth factor axis in human thyroid follicular cells. | 1.66e-05 | 2 | 142 | 2 | 12746216 | |
| Pubmed | Kinetic model for FGF, FGFR, and proteoglycan signal transduction complex assembly. | 1.66e-05 | 2 | 142 | 2 | 15096041 | |
| Pubmed | 2.35e-05 | 14 | 142 | 3 | 17133345 | ||
| Pubmed | A local source of FGF initiates development of the unmyelinated lineage of sensory neurons. | 2.64e-05 | 42 | 142 | 4 | 24198358 | |
| Pubmed | KIF5B gene sequence variation and response of cardiac stroke volume to regular exercise. | 2.92e-05 | 15 | 142 | 3 | 18984674 | |
| Pubmed | BCL11B regulates sutural patency in the mouse craniofacial skeleton. | 3.59e-05 | 16 | 142 | 3 | 26453795 | |
| Pubmed | 4.79e-05 | 407 | 142 | 9 | 12693553 | ||
| Pubmed | Fibroblast growth factor (FGF) 18 signals through FGF receptor 3 to promote chondrogenesis. | 4.95e-05 | 3 | 142 | 2 | 15781473 | |
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 21319186 | ||
| Pubmed | A functional interaction of Ku with Werner exonuclease facilitates digestion of damaged DNA. | 4.95e-05 | 3 | 142 | 2 | 11328876 | |
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 28031461 | ||
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 10864959 | ||
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 14613973 | ||
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 19727229 | ||
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 15647288 | ||
| Pubmed | Amyloidosis causes downregulation of SorLA, SorCS1 and SorCS3 expression in mice. | 4.95e-05 | 3 | 142 | 2 | 31095505 | |
| Pubmed | BMP-2 differentially modulates FGF-2 isoform effects in osteoblasts from newborn transgenic mice. | 4.95e-05 | 3 | 142 | 2 | 23715864 | |
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 23243019 | ||
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 16876430 | ||
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 24063890 | ||
| Pubmed | Heterogeneous nuclear ribonucleoproteins R and Q accumulate in pathological inclusions in FTLD-FUS. | 4.95e-05 | 3 | 142 | 2 | 30755280 | |
| Pubmed | The three sorCS genes are differentially expressed and regulated by synaptic activity. | 4.95e-05 | 3 | 142 | 2 | 15009648 | |
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 22276098 | ||
| Pubmed | Supervillin binding to myosin II and synergism with anillin are required for cytokinesis. | 4.95e-05 | 3 | 142 | 2 | 24088567 | |
| Pubmed | The ancient regulatory-protein family of WD-repeat proteins. | 4.95e-05 | 3 | 142 | 2 | 8090199 | |
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 23891065 | ||
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 11030354 | ||
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 11741978 | ||
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 7891151 | ||
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 22556407 | ||
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 21515689 | ||
| Pubmed | Type III TGF-β receptor promotes FGF2-mediated neuronal differentiation in neuroblastoma. | 4.95e-05 | 3 | 142 | 2 | 24216509 | |
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 24385208 | ||
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 15041185 | ||
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 18171671 | ||
| Cytoband | 10q23-q25 | 5.68e-05 | 4 | 142 | 2 | 10q23-q25 | |
| Cytoband | 7q31.31 | 1.41e-04 | 6 | 142 | 2 | 7q31.31 | |
| GeneFamily | Dyneins, axonemal | 1.02e-04 | 17 | 99 | 3 | 536 | |
| GeneFamily | Lysozymes, c-type | 1.04e-03 | 9 | 99 | 2 | 1174 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.25e-07 | 181 | 142 | 8 | d7e04e0ca549eac6d9b1192b6578f9b54943d54f | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.47e-07 | 185 | 142 | 8 | 6712512100ccef456d2e2bd201d0987986c92ac9 | |
| ToppCell | E16.5-samps-Mesenchymal-Myofibroblast|E16.5-samps / Age Group, Lineage, Cell class and subclass | 1.53e-07 | 186 | 142 | 8 | e044b3428b7eacfdc72d0f57cdabaa1de04c74cd | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.88e-07 | 191 | 142 | 8 | 9032aa974aa1b7b1095b8d1b58dcb087358a5001 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.88e-07 | 191 | 142 | 8 | 5717809a1476c20f65bce722c5a57cff92ee0d7a | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-06 | 169 | 142 | 7 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.21e-06 | 185 | 142 | 7 | 3b2dfc8f4c87be516265dbecfc251276034d0efd | |
| ToppCell | COVID-19-kidney-Fibroblast-1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.37e-06 | 187 | 142 | 7 | 76bfe8c42430a230a8bdf299575c444fb7780f24 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.55e-06 | 189 | 142 | 7 | 45e588b2a4ad9e3ff74e22d9d627ed3571f3b8b8 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.64e-06 | 190 | 142 | 7 | 1121eb607a984c59fbffe7220837fc178745aa55 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.64e-06 | 190 | 142 | 7 | 048b581e3f7ea9fc2f87c0532974bba85c7292c2 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.82e-06 | 192 | 142 | 7 | 992d08092edbc68c47b945deb8708379738c239a | |
| ToppCell | background-Endothelial_cells|background / Sample and Cell Type and Tumor Cluster (all cells) | 3.24e-06 | 196 | 142 | 7 | e6fb0bfab1779ec64a8c35d01519eaafbf62e977 | |
| ToppCell | Bronchial_Biopsy-Epithelial-Goblet_2|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | 9.80e-06 | 153 | 142 | 6 | b25629953ff79aff645845376132b12023067b01 | |
| ToppCell | Globus_pallidus-Macroglia-POLYDENDROCYTE-P3-Tnr-Polydendrocyte.Tnr.Cyth3_(Cyth3)-|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 9.80e-06 | 153 | 142 | 6 | 553dff9688a1996d8f4ba16e60c683593d781389 | |
| ToppCell | Globus_pallidus-Macroglia-POLYDENDROCYTE-P3-Tnr-Polydendrocyte.Tnr.Cyth3_(Cyth3)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 9.80e-06 | 153 | 142 | 6 | 88ca2d2c2ab19fbee13e18951b993ee05dd30f67 | |
| ToppCell | droplet-Liver-Hepatocytes-18m-Myeloid-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.57e-05 | 98 | 142 | 5 | 95162072f3afc95e46f29db3d79ebd930bc09726 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.38e-05 | 179 | 142 | 6 | 1ac79c82c52fa95bb4e170ab20fec0f648db2134 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T6|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 2.38e-05 | 179 | 142 | 6 | 14fc8ccb6b215063d747643f47d780d2b237eb67 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.70e-05 | 183 | 142 | 6 | 7eae9b3b4d1c9b135fa7cff348393d4adec474b4 | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.70e-05 | 183 | 142 | 6 | 5377b4fbd8fdfe68933b4c0965aa9525f7f31591 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_Invariant-Inducer-like|lymph-node_spleen / Manually curated celltypes from each tissue | 2.78e-05 | 184 | 142 | 6 | d97471a4fe17cba6880ccf1a04cc00c741558124 | |
| ToppCell | droplet-Kidney-nan-3m-Endothelial-nan|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.96e-05 | 186 | 142 | 6 | d72cdbb6d79ab33a5823c42e93c2ba566244f64c | |
| ToppCell | 3'-Adult-Appendix-Endothelial-blood_vessel_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.05e-05 | 187 | 142 | 6 | 37d8ee5c8bd6324749e5a2adef1d0482c75da80c | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Endothelial-fenestrated_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.05e-05 | 187 | 142 | 6 | f2a0d0829dc88aa93bfb2eebbbc0ef156a9cba84 | |
| ToppCell | 3'-Adult-Appendix-Endothelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.05e-05 | 187 | 142 | 6 | ec98d5e480b08854dfd0ba6b1dc6610455f90640 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Endothelial-Pecam____fenestrated_capillary_endothelial|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.05e-05 | 187 | 142 | 6 | fa71f9220b288ed6a1d06f347fec42649aac1f13 | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper | 3.14e-05 | 188 | 142 | 6 | 34e1b074a3995aa46ab194eb45115d76d1a5514d | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.23e-05 | 189 | 142 | 6 | 7ab1cfc1657277858339f7258a0c4ae9cb42fdf8 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.33e-05 | 190 | 142 | 6 | 45df8fee00f8949937863159d7aa042e72748d9b | |
| ToppCell | Control-Stromal_mesenchymal|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.43e-05 | 191 | 142 | 6 | 14057205ddb9b4bbc582d1358d13cf36d979a61b | |
| ToppCell | IPF-Endothelial-VE_Arterial|Endothelial / Disease state, Lineage and Cell class | 3.53e-05 | 192 | 142 | 6 | e911e286da26202853f9650ba3cdefe5a5c9b585 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.53e-05 | 192 | 142 | 6 | 72881b280a415e65f87a80ca1369cbb0b722a0c4 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.53e-05 | 192 | 142 | 6 | f4fc2b0121f879bab2bee99dfb5ff2c3ca1c0e1b | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_Invariant-Inducer-like-ILC3|lymph-node_spleen / Manually curated celltypes from each tissue | 3.53e-05 | 192 | 142 | 6 | e16035b3328f9b1b2e28d234c62ba88387540550 | |
| ToppCell | droplet-Kidney-nan-3m-Endothelial-fenestrated_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.53e-05 | 192 | 142 | 6 | 85be54c2cba8eab4c6ef2a85a526f7a9db4cfe73 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.53e-05 | 192 | 142 | 6 | 4e47a02007f562f29ba5910df64d32a0167d0bd1 | |
| ToppCell | droplet-Kidney-nan-3m-Endothelial-Pecam____fenestrated_capillary_endothelial|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.53e-05 | 192 | 142 | 6 | 31a9142d97b690992aabee1a181650deb1a44253 | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.64e-05 | 193 | 142 | 6 | 0a665531d581d4e3941e29d3f95569da8f166447 | |
| ToppCell | Control-Endothelial-Endothelial-Gen_Cap|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.64e-05 | 193 | 142 | 6 | e1d546165dcc2392f540162206852c4717d7306f | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Mesenchymal-fibroblast|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.64e-05 | 193 | 142 | 6 | 24ce1f37cca655415410d2403a52d1ebb3332280 | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.74e-05 | 194 | 142 | 6 | 2d0cff9dc538a14518741e2a96d9d78442c81a72 | |
| ToppCell | LA-02._Fibroblast_II|LA / Chamber and Cluster_Paper | 3.74e-05 | 194 | 142 | 6 | 234d1494c114cce77c619708bbcd8d5ce805f19b | |
| ToppCell | droplet-Kidney-nan-21m-Endothelial-fenestrated_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.85e-05 | 195 | 142 | 6 | 37d22a6448db1f83d098018fbb75a6dd8d9be302 | |
| ToppCell | droplet-Kidney-nan-21m-Endothelial-Pecam____fenestrated_capillary_endothelial|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.85e-05 | 195 | 142 | 6 | 37592b7ad912b381b1edc77f4032983f26e0aa5b | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.08e-05 | 197 | 142 | 6 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | IPF-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 4.08e-05 | 197 | 142 | 6 | f304d42fc4936fe20996e07c8dccc698a6e5e5ef | |
| ToppCell | 10x5'v1-week_12-13-Endothelial-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 4.19e-05 | 198 | 142 | 6 | 122215d9288533ad03562cf777e846504863df9a | |
| ToppCell | 10x5'v1-week_12-13-Endothelial|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 4.19e-05 | 198 | 142 | 6 | 307dd09e6bc820a148f3000f18dae7aedba4be0b | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.19e-05 | 198 | 142 | 6 | 21cf4d81386761d09d0f6829c01c198e5524176d | |
| ToppCell | Striatum-Neuronal|Striatum / BrainAtlas - Mouse McCarroll V32 | 4.43e-05 | 200 | 142 | 6 | c888fd487990cad482a4ca47601cdebc0ca3f3ce | |
| ToppCell | Sepsis-Bac-SEP-Myeloid-cDC1|Bac-SEP / Disease, condition lineage and cell class | 4.43e-05 | 200 | 142 | 6 | cd381644fd8b8674a017d267bfbb00f2668294ae | |
| ToppCell | Tracheal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.43e-05 | 200 | 142 | 6 | c318d14bd6fd6f42c597eb55ac9e2f48008aeb9b | |
| ToppCell | Sepsis-ICU-NoSEP-Lymphocyte-T/NK-NK_CD56bright|ICU-NoSEP / Disease, condition lineage and cell class | 4.43e-05 | 200 | 142 | 6 | c2df917900872453ea17a39928e39d071a6d3339 | |
| ToppCell | primary_visual_cortex-Non-neuronal-oligodendrocyte-Oligo-Oligo_Synpr|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 7.03e-05 | 134 | 142 | 5 | 3dd4b5eddc94c1d49ab23b287ee234db3a55331b | |
| ToppCell | E16.5-samps-Mesenchymal-Myofibroblast-Smooth_Muscle-like_MyoFibroblast|E16.5-samps / Age Group, Lineage, Cell class and subclass | 8.64e-05 | 140 | 142 | 5 | 5623a0a68403fc00166b7d13d13e184a718d9bdd | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-NP-L5_NP_VISp_Trhr_Met|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.02e-04 | 145 | 142 | 5 | 8abbc781f5f69f039617c29a5589d7b6950c2c40 | |
| ToppCell | droplet-Liver-hepatocytes-3m-Epithelial-Hepatocyte_(Pericentral_and_Periportal)|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.09e-04 | 147 | 142 | 5 | 00619115b9a1ec2b967c2992043b41974ece63c4 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-NP|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.27e-04 | 152 | 142 | 5 | b6a7453fbf9f898e4f222b215907c9a110baa2f6 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Dendritic-conventional_dendritic_cell-DC_c1-CLEC9A|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.48e-04 | 157 | 142 | 5 | 19c0599a669803c4db1f174de1ce755e562a50a3 | |
| ToppCell | wk_15-18-Hematologic-Meg-ery-Platelet|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.62e-04 | 160 | 142 | 5 | 768f3cefc3ad4cda229e598cce8bde574cf64bb2 | |
| ToppCell | E18.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.76e-04 | 163 | 142 | 5 | d2fcd6f561748f7d29a051c504f016952ba32d0f | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-myeloid_dendritic_cell-myeloid_dendritic_type_1|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.87e-04 | 165 | 142 | 5 | 479962ce1c3d6636ae62b6709635299748653801 | |
| ToppCell | 10x5'-lymph-node_spleen-Myeloid_Dendritic-pDC|lymph-node_spleen / Manually curated celltypes from each tissue | 2.03e-04 | 168 | 142 | 5 | cfed36fece51871a5abbcde71f6bd5e7212357ff | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.09e-04 | 169 | 142 | 5 | c7fc3a8c44f07c557b60d469717b66e2f5863d38 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.09e-04 | 169 | 142 | 5 | 5f5bec13208f4c3b6eacbba180c8a6402743b76e | |
| ToppCell | RA-01._Fibroblast_I|RA / Chamber and Cluster_Paper | 2.09e-04 | 169 | 142 | 5 | 6373562ab3b1765060212a6a53d6543e7e942e80 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Chat_Htr1f|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.20e-04 | 171 | 142 | 5 | f9ae7964a3740f559431125c17c660549798cccc | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 2.20e-04 | 171 | 142 | 5 | 2e9a20f8980b78325c52065a9c14ab3656267c05 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.26e-04 | 172 | 142 | 5 | e37c0b5b547a7345179ab258dd2141fec7064c17 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L5-6_FEZF2_ANKRD20A1|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.26e-04 | 172 | 142 | 5 | ddecdb1a0791296929790f78b49008f51a130f8b | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L5-6_FEZF2_ANKRD20A1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.39e-04 | 174 | 142 | 5 | 99eb5e1aee136c7039e23b68a43a0fa3d775859f | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-Myeloid_Dendritic_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.45e-04 | 175 | 142 | 5 | bb058e714d21a0ec8532eaf3c7dd2faf78016bc0 | |
| ToppCell | 10x_5'_v1-Neoplastic-Differentiated-like-MES-like|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.45e-04 | 175 | 142 | 5 | 2dcb5145835c3872d0f92f3ece23730cf65487bd | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_artery-D175|Adult / Lineage, Cell type, age group and donor | 2.45e-04 | 175 | 142 | 5 | 0a65ddfa8c2e8efb5b5338cf07661cb78157a23c | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.45e-04 | 175 | 142 | 5 | d52794426f2703a80e91ae0a8ff2d8e0ce4aa4a8 | |
| ToppCell | 10x_5'_v1-Neoplastic-Differentiated-like|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.45e-04 | 175 | 142 | 5 | 3c3cbaeec6ef2f61e6b177c95b999752c2d83ddb | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.45e-04 | 175 | 142 | 5 | 454f03e6109d65f5db08dbb41ecc19ffb6bbc4e0 | |
| ToppCell | droplet-Mammary_Gland-nan-21m-Endothelial-basal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.52e-04 | 176 | 142 | 5 | 27e5115fae5f0f63b333bc99fbf6a6d4c9182c46 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.52e-04 | 176 | 142 | 5 | cb8fd56a4f935cdda19d7ab43382cdda7c307667 | |
| ToppCell | LPS-IL1RA+antiTNF|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.58e-04 | 177 | 142 | 5 | b7fee75de7e96924af488a5baa2334711889ae7c | |
| ToppCell | E18.5-Endothelial-Endothelial_lymphatic-Lymphatic_EC|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.58e-04 | 177 | 142 | 5 | 8dfadd9852e0c256363471a7cfe6af120c8c51e0 | |
| ToppCell | E18.5-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.58e-04 | 177 | 142 | 5 | 767b2af5f224d100b22bed32f86cec1cd17e8711 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.58e-04 | 177 | 142 | 5 | bd602db857f37869ef76d14c05ef522c509f08ee | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6-Exc_L6_THEMIS_LINC00343|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.58e-04 | 177 | 142 | 5 | 921783ed0fe20294d2f384d9136924b679df01bb | |
| ToppCell | E18.5-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.58e-04 | 177 | 142 | 5 | 5ef2527e9b41e62f1724cdabaad9d8979266bb7d | |
| ToppCell | E18.5-Endothelial-Endothelial_lymphatic|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.58e-04 | 177 | 142 | 5 | ae1d2fdd4f67f50c906b27ea084de058c6908aa2 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.58e-04 | 177 | 142 | 5 | 4c069f0d044a96118090b85ca592a21d6b5d9399 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c12-FOXP3|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.58e-04 | 177 | 142 | 5 | f4ddf0ef0eade13b9835a5684a8dbb6f71be4697 | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.72e-04 | 179 | 142 | 5 | a1ea8daa0fe8900f5a04b555c77fe8ebdaa3908d | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.79e-04 | 180 | 142 | 5 | f2f6e83127a4a415e65c76a35efa8175fbd5b5d9 | |
| ToppCell | Control-Fibroblasts-Airway_smooth_muscle|Control / group, cell type (main and fine annotations) | 2.79e-04 | 180 | 142 | 5 | d0de12749ef0f51f0931c6e7b9b99966bdbc3ec1 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.86e-04 | 181 | 142 | 5 | 08f44323bf71b6004a921bbc969c954c75feeb66 | |
| ToppCell | facs-Pancreas-Exocrine-18m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.86e-04 | 181 | 142 | 5 | 269b39ac65790061d54eab47a8eeb024403f0348 | |
| ToppCell | facs-Pancreas-Exocrine-18m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.86e-04 | 181 | 142 | 5 | cd4f744b6b64ba6c22ec07afd1d3058a2546909d | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6-Exc_L6_THEMIS_LINC00343|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.86e-04 | 181 | 142 | 5 | 9de2f2cc5f02e0ca599c9e0d2cb1e1e4b5aac112 | |
| ToppCell | facs-Pancreas-Exocrine-18m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.86e-04 | 181 | 142 | 5 | c8395ae872aa80b3ae1ab7c53e57b3ca15aeb0e2 | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4-T_CD4/CD8|Liver / Manually curated celltypes from each tissue | 2.86e-04 | 181 | 142 | 5 | f2315414e714ac86211546a935660c4be6e85f1b | |
| ToppCell | pdx-Tumor_cells-T6|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 2.94e-04 | 182 | 142 | 5 | 7b24a4f712e1ae1525e8f1c8ec4e1fc43489cbee | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_Invariant-Inducer-like-ILC3|lymph-node_spleen / Manually curated celltypes from each tissue | 3.09e-04 | 184 | 142 | 5 | 479e60f76c191253e23699c9dd7ef7efc08c59ad | |
| Disease | Seizures | 9.59e-06 | 218 | 139 | 8 | C0036572 | |
| Disease | serum metabolite measurement | TSPAN15 MYH10 CFAP251 CYP2C9 KDM4C FOLH1 DDR2 PBX4 GPAM CPED1 ST6GALNAC3 DOCK7 SORCS3 IL33 | 1.56e-04 | 945 | 139 | 14 | EFO_0005653 |
| Disease | Thymoma | 2.18e-04 | 5 | 139 | 2 | C0040100 | |
| Disease | Kallmann Syndrome | 2.46e-04 | 26 | 139 | 3 | C0162809 | |
| Disease | obstructive sleep apnea | 2.71e-04 | 66 | 139 | 4 | EFO_0003918 | |
| Disease | Kallmann Syndrome 2 (disorder) | 3.26e-04 | 6 | 139 | 2 | C1563720 | |
| Disease | Kallmann Syndrome 1 | 3.26e-04 | 6 | 139 | 2 | C1563719 | |
| Disease | Hypogonadism with anosmia | 3.26e-04 | 6 | 139 | 2 | cv:C0162809 | |
| Disease | Kallmann syndrome, type 3, recessive | 3.26e-04 | 6 | 139 | 2 | C2930927 | |
| Disease | chemokine (C-C motif) ligand 27 measurement | 3.40e-04 | 70 | 139 | 4 | EFO_0008082 | |
| Disease | Crohn's disease (is_marker_for) | 3.42e-04 | 29 | 139 | 3 | DOID:8778 (is_marker_for) | |
| Disease | neuropilin-1 measurement | 4.56e-04 | 7 | 139 | 2 | EFO_0020603 | |
| Disease | Septo-Optic Dysplasia | 4.56e-04 | 7 | 139 | 2 | C0338503 | |
| Disease | Thymic Carcinoma | 4.56e-04 | 7 | 139 | 2 | C0205969 | |
| Disease | feeling nervous measurement | 7.75e-04 | 87 | 139 | 4 | EFO_0009597 | |
| Disease | ulcerative colitis (is_marker_for) | 8.90e-04 | 40 | 139 | 3 | DOID:8577 (is_marker_for) | |
| Disease | Head and Neck Carcinoma | 9.67e-04 | 10 | 139 | 2 | C3887461 | |
| Disease | Malignant Head and Neck Neoplasm | 1.18e-03 | 44 | 139 | 3 | C0278996 | |
| Disease | cognitive function measurement | DOCK3 NSF KDM4C CNOT10 WRN EXT1 ZDBF2 LYZL1 FBXL4 THBD NRXN3 ST6GALNAC3 SORCS3 VAV3 DNAH5 GABPA | 1.21e-03 | 1434 | 139 | 16 | EFO_0008354 |
| Disease | bilirubin measurement | 1.22e-03 | 442 | 139 | 8 | EFO_0004570 | |
| Disease | diet measurement | NSF TRPC3 UBAP1 DGKG NLGN1 DNAH14 ZBTB46 NRXN3 SLC25A13 SORCS3 CAPZA3 DNAH5 WDR49 | 1.41e-03 | 1049 | 139 | 13 | EFO_0008111 |
| Disease | nicotine dependence (implicated_via_orthology) | 1.41e-03 | 12 | 139 | 2 | DOID:0050742 (implicated_via_orthology) | |
| Disease | Osteosarcoma | 1.43e-03 | 47 | 139 | 3 | C0029463 | |
| Disease | mental or behavioural disorder | 1.62e-03 | 179 | 139 | 5 | EFO_0000677 | |
| Disease | facial morphology measurement | 1.70e-03 | 466 | 139 | 8 | EFO_0007841 | |
| Disease | C-reactive protein measurement | DOCK3 CFAP251 ZNF573 FOLH1 IFT172 PBX4 NLGN1 PTPN2 ZBTB46 GRTP1 ZNF644 DOCK7 KDM2B AIM2 | 1.71e-03 | 1206 | 139 | 14 | EFO_0004458 |
| Disease | treatment-resistant hypertension | 1.79e-03 | 109 | 139 | 4 | EFO_1002006 | |
| Disease | response to simvastatin, total cholesterol change measurement, response to fenofibrate | 1.81e-03 | 51 | 139 | 3 | EFO_0007806, GO_1901557, GO_1903491 | |
| Disease | glycodeoxycholate measurement | 1.93e-03 | 14 | 139 | 2 | EFO_0010493 | |
| Disease | Spastic Paraplegia, Hereditary | 1.93e-03 | 14 | 139 | 2 | C0037773 | |
| Disease | Bipolar Disorder | 1.96e-03 | 477 | 139 | 8 | C0005586 | |
| Disease | Polydactyly | 2.32e-03 | 117 | 139 | 4 | C0152427 | |
| Disease | transferrin saturation measurement | 2.53e-03 | 16 | 139 | 2 | EFO_0006333 | |
| Disease | colorectal health | 2.69e-03 | 201 | 139 | 5 | EFO_0008460 | |
| Disease | Idiopathic hypogonadotropic hypogonadism | 3.21e-03 | 18 | 139 | 2 | C0342384 | |
| Disease | pulmonary hypertension (is_marker_for) | 3.46e-03 | 64 | 139 | 3 | DOID:6432 (is_marker_for) | |
| Disease | exercise test | 3.96e-03 | 20 | 139 | 2 | EFO_0004328 | |
| Disease | response to ketamine | 4.27e-03 | 69 | 139 | 3 | EFO_0009748 | |
| Disease | HIV-1 infection, Susceptibility to viral and mycobacterial infections | 4.36e-03 | 21 | 139 | 2 | EFO_0000180, Orphanet_391311 | |
| Disease | Nephritis, Tubulointerstitial | 4.36e-03 | 21 | 139 | 2 | C0041349 | |
| Disease | serum alanine aminotransferase measurement, response to combination chemotherapy | 4.63e-03 | 71 | 139 | 3 | EFO_0004735, EFO_0007965 | |
| Disease | allergic disease, age at onset | 4.63e-03 | 71 | 139 | 3 | EFO_0004847, MONDO_0005271 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GNCNMLRKTVKSKEY | 136 | Q96KX2 | |
| IGMCFFGKKKYVAAI | 276 | Q96RK4 | |
| DKGKKRTLEECFQMF | 56 | Q6DHV7 | |
| SGRYDCKTTMTKVKF | 816 | Q9NXG0 | |
| TITMGRYKEFLQGKC | 936 | A4D0V7 | |
| YCGAVAKRQEKKGME | 266 | Q8IUR6 | |
| TMKCKEGDKVRLTFF | 301 | O14862 | |
| KTVRYAQMLEKAGCQ | 156 | Q6P1R4 | |
| YKSGYNTMEKCIEKQ | 1141 | Q8N2N9 | |
| LNMTKNYTKTCGFVV | 311 | Q96K78 | |
| RKKNVFMYGCSIKET | 1021 | Q9UPW5 | |
| RMYSKGASEIVLKKC | 621 | Q01814 | |
| NIMNFKKCSIAGVTY | 436 | Q9NTI2 | |
| SGYKVKLFNATTKMC | 816 | Q8TBY9 | |
| GAESEKYICMNKRGK | 101 | O60258 | |
| GKSSMIQRYCKGIFT | 21 | Q9ULC3 | |
| AKNCYRMVILGSSKV | 21 | Q9Y272 | |
| FCLYGNIEKVKFMKT | 356 | Q8WVV9 | |
| RFSYMAIIEGAKCIK | 266 | P17706 | |
| KKVKCTAPQYVDFVM | 101 | Q70IA6 | |
| YKSGYNTMEKCIEKQ | 1566 | Q5JPF3 | |
| GREAKMICFKSVAKT | 636 | Q8IYF1 | |
| ILGKCVVMFVKEYFK | 1031 | Q86U86 | |
| ICARKIVKETQGMNY | 111 | Q6UWQ5 | |
| ICAKKIVKETQGMNY | 111 | Q7Z4W2 | |
| MFAKGVKIFKEVQCY | 291 | Q16832 | |
| MICKVQGKRFVYKFV | 386 | Q06546 | |
| DMKINCSGKIVIARY | 191 | Q04609 | |
| CGTCREKYLAMKTKS | 3036 | Q15751 | |
| FKSSLGSQMLCKKIY | 1401 | Q9NRD8 | |
| KSAFLCGVMKTYRQR | 91 | O60506 | |
| YSKCKKIMIERGELF | 86 | Q14232 | |
| MKLRRKTGYSFVNCK | 51 | P43897 | |
| FKTEKRLCKMFYAVT | 276 | Q9NS67 | |
| TIIKSGDQTFYKFMK | 241 | Q9BRP1 | |
| GKETEFYLCMNRKGK | 101 | O76093 | |
| ARNGQKKCMSKLLEY | 106 | Q8IYU2 | |
| RQKEYKCGDLVFAKM | 6 | P51858 | |
| VQNKSAFLCGVMKTY | 91 | O43390 | |
| AFLCGVMKTYRQREK | 96 | O43390 | |
| ADTKMKIYGEVVFKC | 426 | Q9Y4C0 | |
| YGKVAKLCTCRKDMV | 301 | Q9H3R0 | |
| MSLIRKKGFYKQDVN | 1 | O15264 | |
| VGKDKKCVYMTASRE | 921 | Q9UBG0 | |
| SLYTFDKAKQCIGTM | 81 | P46459 | |
| YKCKAKNLAGMSEAV | 326 | Q3SXY7 | |
| ICMKGKAKYKASENA | 336 | Q96CW1 | |
| KYARMLATKVGCNVS | 351 | Q8N2Q7 | |
| FLVKRKTISFYGCMT | 101 | Q8NGH3 | |
| QRYCEKSMISRKLFG | 496 | Q96FC9 | |
| TGMKSKEARKYIFNS | 456 | Q9H422 | |
| QKALECYRKGNAFMK | 826 | Q9UG01 | |
| RENKVFMRKFKIGYS | 506 | O14786 | |
| IRYKKNMGKFQEEAT | 266 | Q9BYU1 | |
| CVKTYSKAKRSGEVM | 321 | P49619 | |
| KLRSGLMIKKEACYF | 46 | O95760 | |
| VKKYCLMSVKGCFTD | 226 | Q8NHM5 | |
| FIKSNFRKCIEKPYM | 606 | A2AJT9 | |
| KIGCTVNLMNFYKSE | 1216 | Q8IZD9 | |
| EYKGKKVFERMNSLT | 1371 | Q96N67 | |
| SIYKGKKCRMESCFD | 91 | Q16394 | |
| VVSMCKYFQESVKKL | 2621 | Q8TD57 | |
| QVARGMEYLASKKCI | 606 | P11362 | |
| DYDVIASMIGAKCKK | 466 | Q9UKA2 | |
| RKIGCYAAMKKKIYA | 411 | Q9H2C0 | |
| ICDKFKQITKGSFVM | 286 | Q5TC63 | |
| KSKVTCQYKMGEENI | 226 | Q6ZRK6 | |
| KGASKRCSVCKMVIY | 326 | Q8IV38 | |
| KFITEKMGNKYLQRT | 3031 | Q0VDD8 | |
| CKSDIFYPKMKGQQR | 366 | Q6MZM0 | |
| SCYSGDSMLQKYKVK | 66 | Q96KT0 | |
| SIKGVCANRYLAMKE | 206 | P09038 | |
| YSKQSKMRKRGSIVC | 101 | Q14558 | |
| LYMVRFKGTKAQFSC | 166 | P43166 | |
| TTFFKRGKKLKCYLM | 426 | O75881 | |
| SKVGMSQEKYKTLQC | 896 | Q6PJP8 | |
| KSKYFMPFSAGKRIC | 421 | P11712 | |
| YGYVCATKIMKLRKI | 651 | Q9NQC7 | |
| CNYEARKLGVKKLMN | 91 | Q9UNA4 | |
| ELNSGKVMYAFCRVK | 56 | Q9UJU6 | |
| KKGMFRTVGQLYKES | 646 | P35580 | |
| KKEVITSMDCFKRYN | 1131 | Q8TE73 | |
| KYGRLFVEAFLKQCM | 1296 | Q9BXW9 | |
| MKAVAKQYKRATASG | 481 | Q8NET4 | |
| DKKTFYKTADICQML | 81 | Q15545 | |
| KKQGAARAKMEYKCA | 541 | P07204 | |
| KSAMETVLQYCKGKN | 2081 | O95425 | |
| TKYTCSFCGKTKMKR | 36 | A6NKH3 | |
| LEKDFSSMKKYCQVI | 146 | P39023 | |
| CTDGLREKYTAKAQM | 801 | Q9UPU3 | |
| MCRSKQASTLFYLGK | 1466 | Q8IVG5 | |
| VVYSCVEGKMYTARK | 121 | P29218 | |
| FLAKRKVISYFGCMT | 136 | Q8NGC0 | |
| YCLVKNAVKMFKDIG | 776 | Q9HCL2 | |
| FKSNVTKTMKGFEYI | 151 | Q9Y255 | |
| MKDAYVQKLVKVCNG | 126 | Q8NEK8 | |
| KRMSYCDGVFKKETG | 191 | Q8NDV1 | |
| KTVINDDARYMKGCL | 466 | O15457 | |
| VSRYNKFMKICALTK | 1031 | Q14191 | |
| RMKGTFCIALEKFSK | 146 | Q7Z745 | |
| KMYSAEGRRKVFSTC | 266 | Q8NGG2 | |
| VGELMYKNSFDCFKK | 366 | Q9UJS0 | |
| YKVRAYIQMKSLKAC | 221 | Q9H9A5 | |
| RNQSVSMFVECGKKY | 171 | Q17RW2 | |
| FTYRCSKEGCKKKEM | 96 | Q8N6M9 | |
| MKVCEKVQRKGTTSY | 121 | Q14186 | |
| YKKCGKAFNISSMFT | 231 | A8MXY4 | |
| FVCRMCGKKYTRKDQ | 401 | Q5TC79 | |
| TGMKPYECKVCRKTF | 521 | Q86YE8 | |
| YECVLRAMKKKGENI | 406 | Q9NZ09 | |
| EIKTMAGFINYKICR | 266 | Q7Z392 | |
| KCQLKSLGFDKVFMY | 346 | P07911 | |
| IASVCKAIKKMDGEY | 486 | Q96T58 | |
| DLVYKQKMGKCDLTF | 266 | Q9BR01 | |
| CYPTFVDMKRKKQVI | 156 | A6NCN8 | |
| SEKKKTRRCNGFKMF | 16 | Q9NPD5 | |
| TMCGYKTIDKERFSV | 196 | O95858 | |
| YKERSTCMKETQKPY | 586 | Q8IV35 | |
| TQTSCKNYPVMKRKI | 1946 | Q9HCK1 | |
| EKSYKCTVCNKVFMR | 536 | Q8N4W9 | |
| KACFVADNKEMYVKG | 36 | Q9UKX3 | |
| GYTKKVCVMTKIFYL | 486 | Q8IYM2 | |
| VCFVTVKNNTMKYFK | 331 | Q8NFJ6 | |
| MRCKTCGEYIYKGKK | 41 | Q9BW85 | |
| CGKKMYSFLRGTKQL | 206 | O95859 | |
| VVGSSKKSATYICKM | 576 | Q9H582 | |
| KLYINVKMGCEKFAD | 1301 | Q8N9V7 | |
| FYRKTKLVGFQDMEC | 121 | Q9NS68 | |
| LGKSCQYVKEAKMEE | 451 | Q6NXT6 | |
| IRYSQMEKGKAEACS | 881 | Q9UL62 | |
| CKVCKYYTVTKGDME | 881 | Q9C0G0 | |
| KTQRMFVGKKIYECN | 91 | Q6ZN57 | |
| SECGKGFTMKRYLVV | 346 | Q8N883 | |
| RKSERKCMQGKYAGA | 701 | Q8WY21 | |
| RYKGLMDCAKQVLQK | 261 | Q9HC21 | |
| EKPYMCKECRKTFSQ | 461 | Q96ND8 | |
| MKYKSEGKCFSVLGF | 331 | P13010 | |
| DKKYVCKVCSRVFMS | 471 | Q86UZ6 | |
| DYRKLSMQCKDFVVG | 246 | Q13507 | |
| MFKACEDSKRKARGY | 36 | Q8IU80 | |
| KQCGKVFRVASQLKM | 426 | C9JN71 | |
| GEVCNMISKKYSEFL | 36 | O43264 | |
| VCKRKGDNYEMKEII | 431 | Q9UKW4 | |
| CMYCVKEFSRGKNEK | 136 | O75132 |